Home
Peloton Therapeutics, Inc.

Peloton Therapeutics, Inc. Market Share Analysis for July 2026

Peloton Therapeutics is translating groundbreaking scientific insights into first-in-class oral medicines to fight cancer and other serious conditions.

Health > Biotechnology and Pharmaceuticals

Domainpelotontherapeutics.com

Year Founded2010

Employees51 - 200

Annual Revenue$5M - $10M

Peloton Therapeutics, Inc.

Peloton Therapeutics, Inc. (including company regionals)

pelotontherapeutics.com

See more website traffic and engagement information

Peloton Therapeutics, Inc. Revenue up to July 2026 is 5M - 10M

revenue generated by Peloton Therapeutics, Inc. top domains

Peloton Therapeutics, Inc. top domains revenue over 3 years

Revenue for Peloton Therapeutics, Inc. top domains

pelotontherapeutics.com5M - 10M

See more with Sales Intelligence

Total visits to Peloton Therapeutics, Inc.'s top domains

Understand Peloton Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Peloton Therapeutics, Inc.'s top domains

Analyze Peloton Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Peloton Therapeutics, Inc.'s top domains

See how Peloton Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Peloton Therapeutics, Inc. top competitors by domain

Top similar sites in July 2026, ranked by their affinity

cambrex.comCompany NameCambrexEmployees1001 - 5000HQUnited States, New Jersey, East RutherfordAnnual revenue$500M - $1BTotal visits39.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Peloton Therapeutics, Inc.

These are the website technologies, by industry, used by Peloton Therapeutics, Inc. top domains

Advertising (3)

DoubleClick

Audio Video Media (2)

MPEG-DASH

Content Management System (2)

WordPress

Email Services (2)

Microsoft Exchange Online

More Technologies

4

See all

News & Signals from Peloton Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsWallace left Peloton Therapeutics as chief scientific officer on Jan 1st '19.Wallace joined BridgeBio in 2019 after serving as the chief scientific officer at Peloton Therapeutics.

NewsPeloton Therapeutics acquired Arqule on Jan 1st '19.These include the $1.1 billion Peloton Therapeutics buy, the $2.7 billion purchase of ArQule and the $773 million Tilos Therapeutics takeover in 2019, all of which are focused on cancer.

NewsMerck & Co acquired Peloton Therapeutics for $1.05B on Jan 1st '19.Merck & Co. agreed to acquire cancer drug developer Peloton Therapeutics Inc. for $1.05 billion in cash, adding to a list of deals in 2019 by pharmaceutical companies looking to bolster their cancer treatment portfolios.